中华内科杂志
中華內科雜誌
중화내과잡지
CHINESE JOURNAL OF INTERNAL MEDICINE
2013年
1期
38-41
,共4页
王红玲%罗琳洁%寇继光%袁岸龙%杨桂芳%王敏%夏冰
王紅玲%囉琳潔%寇繼光%袁岸龍%楊桂芳%王敏%夏冰
왕홍령%라림길%구계광%원안룡%양계방%왕민%하빙
乳糜泻%肠易激综合征%患病率%生物学标记
乳糜瀉%腸易激綜閤徵%患病率%生物學標記
유미사%장역격종합정%환병솔%생물학표기
Celiac disease%Irritable bowel syndrome%Prevalence%Biological markers
目的 筛查伴有血清学特征的成人乳糜泻在中国湖北人群特别是腹泻型肠易激综合征(D-IBS)患者中的患病情况.方法 依据罗马Ⅲ标准选取282例D-IBS患者,并以296例年龄和性别匹配并且无腹泻症状的体检人群作为对照组,采用ELISA法检测血清IgA/IgG型抗人组织转谷氨酰胺酶/脱酰胺麸朊肽抗体(抗htTG/DGP)水平.血清抗体阳性者建议行去麸质饮食治疗5~6个月,观察临床疗效,并复查血清中抗htTG/DGP水平.结果 纳入试验的578例研究对象中,血清抗htTG/DGP阳性7例,其中D-IBS组5例(5/282,1.77%),对照组2例(2/296,0.68%).抗htTG/DGP阳性研究对象中,4例同意并进行了平均5.2个月的去麸质饮食治疗,随访观察显示其临床症状均得到明显改善,并伴随血清抗htTG/DGP水平降低.结论 乳糜泻在中国可能并非罕见疾病,特别是在D-IBS患者乳糜泻发病率更高,因此,在IBS患者中进行乳糜泻血清学筛查具有重要意义.
目的 篩查伴有血清學特徵的成人乳糜瀉在中國湖北人群特彆是腹瀉型腸易激綜閤徵(D-IBS)患者中的患病情況.方法 依據囉馬Ⅲ標準選取282例D-IBS患者,併以296例年齡和性彆匹配併且無腹瀉癥狀的體檢人群作為對照組,採用ELISA法檢測血清IgA/IgG型抗人組織轉穀氨酰胺酶/脫酰胺麩朊肽抗體(抗htTG/DGP)水平.血清抗體暘性者建議行去麩質飲食治療5~6箇月,觀察臨床療效,併複查血清中抗htTG/DGP水平.結果 納入試驗的578例研究對象中,血清抗htTG/DGP暘性7例,其中D-IBS組5例(5/282,1.77%),對照組2例(2/296,0.68%).抗htTG/DGP暘性研究對象中,4例同意併進行瞭平均5.2箇月的去麩質飲食治療,隨訪觀察顯示其臨床癥狀均得到明顯改善,併伴隨血清抗htTG/DGP水平降低.結論 乳糜瀉在中國可能併非罕見疾病,特彆是在D-IBS患者乳糜瀉髮病率更高,因此,在IBS患者中進行乳糜瀉血清學篩查具有重要意義.
목적 사사반유혈청학특정적성인유미사재중국호북인군특별시복사형장역격종합정(D-IBS)환자중적환병정황.방법 의거라마Ⅲ표준선취282례D-IBS환자,병이296례년령화성별필배병차무복사증상적체검인군작위대조조,채용ELISA법검측혈청IgA/IgG형항인조직전곡안선알매/탈선알부원태항체(항htTG/DGP)수평.혈청항체양성자건의행거부질음식치료5~6개월,관찰림상료효,병복사혈청중항htTG/DGP수평.결과 납입시험적578례연구대상중,혈청항htTG/DGP양성7례,기중D-IBS조5례(5/282,1.77%),대조조2례(2/296,0.68%).항htTG/DGP양성연구대상중,4례동의병진행료평균5.2개월적거부질음식치료,수방관찰현시기림상증상균득도명현개선,병반수혈청항htTG/DGP수평강저.결론 유미사재중국가능병비한견질병,특별시재D-IBS환자유미사발병솔경고,인차,재IBS환자중진행유미사혈청학사사구유중요의의.
Objective To screen the prevalence of celiac disease with serologic markers in the central Chinese population,specifically in patients with chronic diarrhea-predominant irritable bowel syndrome (D-IBS).Methods A total of 282 adult patients with D-IBS were selected based on ROME Ⅲ criteria with 296 age and sex matched consecutive healthy individuals as controls.A gluten-free diet (GFD) was advised in subjects positive for IgA/IgG anti-htTG/DGP antibodies and the serologic antibodies were retested after the GFD.Results Among the 578 study subjects,five D-IBS patients (5/282,1.77%) and two healthy controls (2/296,0.68%) were positive for anti-htTG/DGP antibodies.Among the seven positive cases,one was lost to follow-up and only four were evaluated during GFD therapy for an average of 5.2 months with clinical and/or serological manifestations improved.Conclusions The prevalence of celiac disease may not be uncommon in China.Compared with the healthy population,patients with D-IBS tend to be affected more.Thus,it is significantly important to conduct routine screening for celiac disease in patients with D-IBS.